Do kinetics of the humoral response to Cryptococcus neoformans proteins during murine cryptococcosis reflect outcome?

Infection and Immunity

Volumn 68, Issue 6, 2000, Pages 3724-3726

  Neuville, Segolene ^a   Lortholary, Olivier ^a   Dromer, Francoise ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL PROTEIN; MEMBRANE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HUMORAL IMMUNITY; KINETICS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; CRYPTOCOCCOSIS; FUNGEMIA; KINETICS; MALE; MICE; PROGNOSIS;

EID: 0034087263     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.6.3724-3726.2000     Document Type: Article

References (21)

1. Buchanan, K. L., and J. W. Murphy. 1998. What makes Cryptococcus neoformans a pathogen? Emerg. Infect. Dis. 4:71-83.
2. Casadevall, A., and J. R. Perfect. 1998. Cryptococcus neoformans, p. 351-380. American Society for Microbiology, Washington, D.C.
3. Chen, L.-C., and A. Casadevall. 1999. Variants of a Cryptococcus neoformans strain elicit different inflammatory responses in mice. Clin. Diagn. Lab. Immunol. 6:266-268.
4. Chen, L.-C., D. L. Goldman, T. L. Doering, L.-A. Pirofski, and A. Casadevall. 1999. Antibody response to Cryptococcus neoformans proteins in rodents and humans. Infect. Immun. 67:2218-2224.
5. Chen, L.-C., L.-A. Pirofski, and A. Casadevall. 1997. Extracellular proteins of Cryptococcus neoformans and host antibody response. Infect. Immun. 65: 2599-2605.
6. Diamond, R. D., and J. E. Bennett. 1974. Prognostic factors in cryptococcal meningitis: a study in 111 cases. Ann. Intern. Med. 80:176-181.
7. Dromer, F., J. Charreire, A. Contrepois, C. Carbon, and P. Yeni. 1987. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect. Immun. 55:749-752.
8. Dromer, F., D. W. Denning, D. A. Stevens, A. Noble, and J. R. Hamilton. 1995. Anti-Cryptococcus neoformans antibodies in patients with AIDS and cryptococcosis. Serodiagn. Immunother. Infect. Dis. 7:181-188.
9. Dromer, F., C. Perronne, J. Barge, J. L. Vildé, and P. Yeni. 1989. Role of specific IgG and complement during the initial course of experimental cryptococcosis. Clin. Exp. Immunol. 78:412-417.
10. Dromer, F., P. Yeni, and J. Charreire. 1988. Genetic control of the humoral response to cryptococcal polysaccharide in mice. Immunogenetics 28:417-424.
11. Eckert, T. F., and T. R. Kozel. 1987. Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide. Infect. Immun. 55:1895-1899.
12. Hamilton, A. J., J. I. Figueroa, L. Jeavons, and R. A. Seaton. 1997. Recognition of cytoplasmic yeast antigens of Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. gattii by immune human sera. FEMS Immunol. Med. Microbiol. 17:111-119.
13. Kakeya, H., H. Udono, N. Ikuno, Y. Yamamoto, K. Mitsutake, T. Miyazaki, K. Tomono, H. Koga, T. Tashiro, E. Nakayama, and S. Kohno. 1997. A 77-kilodalton protein of Cryptococcus neoformans, a member of the heat shock protein 70 family, is a major antigen detected in the sera of mice with pulmonary cryptococcosis. Infect. Immun. 65:1653-1658.
14. Kakeya, H., H. Udono, S. Maesaki, E. Sasaki, S. Kawamura, M. A. Hossain, Y. Yamamoto, T. Sawai, M. Fukuda, K. Mitsutake, Y. Miyazaki, K. Tomono, T. Tashiro, E. Nakayama, and S. Kohno. 1999. Heat shock protein 70 (Hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis. Clin. Exp. Immunol. 115:485-490.
15. Lortholary, O., L. Improvisi, M. Nicolas, F. Provost, B. Dupont, and F. Dromer. 1999. Fungemia during murine cryptococcosis sheds some light on pathophysiology. Med. Mycol. 37:169-174.
16. Lortholary, O., L. Improvisi, N. Rayhane, F. Gray, C. Fitting, J. M. Cavaillon, and F. Dromer. 1999. Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection. Infect. Immun. 67:6314-6320.
17. Lovchik, J. A., J. A. Wilder, G. B. Huffnagle, R. Riblet, C. R. Lyons, and M. F. Lipscomb. 1999. Ig heavy chain complex-linked genes influence the immune response in a murine cryptococcal infection. J. Immunol. 163:3907-3913.
18. Mukherjee, J., G. Nussbaum, M. D. Scharff, and A. Casadevall. 1995. Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J. Exp. Med. 181:405-409.
19. Mukherjee, S., S. C. Lee, and A. Casadevall. 1995. Antibodies to Cryptococcus neoformans glucuronoxylomannon enhance antifungal activity of murine macrophages. Infect. Immun. 63:573-579.
20. Savoy, A. C., D. M. Lupan, P. B. Manalo, J. S. Roberts, A. M. Schlageter, L. C. Weinhold, and T. R. Kozel. 1997. Acute lethal toxicity following passive immunization for treatment of murine cryptococcosis. Infect. Immun. 65: 1800-1807.
21. Yuan, R. R., G. Spira, J. Oh, M. Paizi, A. Casadevall, and M. D. Scharff. 1998. Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice. Infect. Immun. 66:1057-1062.